Active Ingredient History
Panax notoginseng is a species of the genus Panax, and it is commonly referred to in English as Chinese ginseng or notoginseng. In Chinese it is called tiánqī, tienchi ginseng, sānqī or sanchi, three-seven root, and mountain plant. P. notoginseng belongs to the same scientific genus as Panax ginseng. In Latin, the word panax means "cure-all", and the family of ginseng plants is one of the best-known herbs. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Altitude Sickness (Phase 3)
Alzheimer Disease (Phase 1/Phase 2)
Angina Pectoris (Phase 3)
Anxiety ()
Atherosclerosis (Phase 4)
Blood Pressure (Phase 2)
Bone Diseases, Metabolic (Phase 2/Phase 3)
Brain Waves (Phase 4)
Breast Neoplasms (Phase 2)
Cancer Survivors (Early Phase 1)
Cognition (Early Phase 1)
Colonic Neoplasms (Early Phase 1)
Colorectal Neoplasms (Phase 2)
Community-Acquired Infections (Phase 3)
COVID-19 (Phase 2/Phase 3)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 2 (Phase 2/Phase 3)
Endothelium (Phase 2)
Fatigue (Phase 4)
Fatigue Syndrome, Chronic (Phase 3)
Fibromyalgia (Early Phase 1)
Healthy Aging (Phase 2/Phase 3)
Healthy Volunteers (Phase 4)
Hematoma (Phase 4)
Herbal Medicine (Phase 2/Phase 3)
HIV Infections (Phase 2)
Hyperglycemia (Phase 3)
Hyperlipidemias (Phase 2)
Hypersensitivity (Phase 4)
Hypertension (Phase 3)
Hypotension (Phase 2/Phase 3)
Immune System Diseases (Phase 4)
Infertility, Male (Phase 4)
Insulin Resistance (Phase 1/Phase 2)
Ischemic Stroke (Phase 4)
Leukemia (Phase 3)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1)
Lymphoma (Phase 3)
Lymphoproliferative Disorders (Phase 3)
Malabsorption Syndromes (Phase 1)
Memory Disorders (Phase 3)
Metabolic Syndrome (Phase 1)
Multiple Myeloma (Phase 3)
Multiple Sclerosis (Phase 2)
Myelodysplastic Syndromes (Phase 3)
Myeloproliferative Disorders (Phase 3)
Neoplasms (Phase 3)
Neoplasms, Second Primary (Phase 2)
Obesity (Phase 2/Phase 3)
Oxidative Stress (Phase 2/Phase 3)
Palliative Care (Phase 2)
Palliative Medicine (Phase 2)
Precancerous Conditions (Phase 3)
Prehypertension (Phase 3)
Psychological Distress (Phase 3)
Psychotic Disorders (Phase 1/Phase 2)
Respiratory Tract Infections (Phase 3)
Schizophrenia (Phase 1/Phase 2)
Sports Medicine (Early Phase 1)
Sprains and Strains (Phase 1)
Stress, Psychological (Phase 1/Phase 2)
Tardive Dyskinesia (Phase 1/Phase 2)
Xerostomia (Phase 4)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
